Article metrics

Download PDFPDF

AB0954 A randomised, double-blind trial comparing the efficacy, safety and immunogenicity of msb11022, a proposed biosimilar of adalimumab, versus adalimumab originator in patients with moderate-to-severe plaque psoriasis
Free

 

Online download statistics by month:

Online download statistics by month: June 2018 to April 2022

AbstractFullPdf
Jun 20182405
Jul 20185404
Aug 20186608
Sep 20183205
Oct 201874015
Nov 20184407
Dec 2018104015
Jan 201967010
Feb 20197205
Mar 201958012
Apr 201974015
May 201992013
Jun 20195808
Jul 201964010
Aug 20194404
Sep 20192705
Oct 201946012
Nov 20195606
Dec 20193303
Jan 20204606
Feb 20201603
Mar 20202302
Apr 2020607
May 20201402
Jun 20202308
Jul 20203508
Aug 20202006
Sep 20201601
Oct 20201809
Nov 20201508
Dec 20202109
Jan 2021604
Feb 20213204
Mar 2021804
Apr 20211004
May 20211204
Jun 2021002
Jul 2021008
Aug 2021007
Sep 2021004
Oct 202126016
Nov 202144015
Dec 20214104
Jan 20223002
Feb 20223000
Mar 20222400
Apr 20222205
Total16270314